![Jing Gao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jing Gao
Direktor/Vorstandsmitglied bei Jiangxi ZSM Pharmaceutical Co., Ltd.
Profil
Jing Gao currently works as a Director at Jiangxi ZSM Pharmaceutical Co., Ltd.
Aktive Positionen von Jing Gao
Unternehmen | Position | Beginn |
---|---|---|
Jiangxi ZSM Pharmaceutical Co., Ltd.
![]() Jiangxi ZSM Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Jiangxi ZSM Pharmaceutical Co., Ltd. is a large-scale eye care enterprise based in Fuzhou, China. The Chinese company specializes in eye drops and is known for its brand Zhenshiming, which offers a range of eye drops for various eye conditions such as eye fatigue, myopia, dry eye syndrome, redness, cataracts, and infections. Zhenshiming eye drops are also known for their ability to protect eyes from screen damage and relieve eye fatigue. The company was founded in 2006, and the CEO is Fa Hong Xu. Jiangxi ZSM Pharmaceutical Co. was acquired by Jiangxi ZSM Pharmaceutical Co. Ltd. /Pvt Grp/ on December 16, 2021 for $263.82 million. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Jiangxi ZSM Pharmaceutical Co., Ltd.
![]() Jiangxi ZSM Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Jiangxi ZSM Pharmaceutical Co., Ltd. is a large-scale eye care enterprise based in Fuzhou, China. The Chinese company specializes in eye drops and is known for its brand Zhenshiming, which offers a range of eye drops for various eye conditions such as eye fatigue, myopia, dry eye syndrome, redness, cataracts, and infections. Zhenshiming eye drops are also known for their ability to protect eyes from screen damage and relieve eye fatigue. The company was founded in 2006, and the CEO is Fa Hong Xu. Jiangxi ZSM Pharmaceutical Co. was acquired by Jiangxi ZSM Pharmaceutical Co. Ltd. /Pvt Grp/ on December 16, 2021 for $263.82 million. | Distribution Services |